Scoping review: hotspots for COVID-19 urological research: what is being published and from where?
- PDF / 951,540 Bytes
- 10 Pages / 595.276 x 790.866 pts Page_size
- 38 Downloads / 173 Views
TOPIC PAPER
Scoping review: hotspots for COVID‑19 urological research: what is being published and from where? Liang G. Qu1,2,3 · Marlon Perera1,2 · Nathan Lawrentschuk2,4,5 · Rainy Umbas6 · Laurence Klotz7 Received: 26 June 2020 / Accepted: 30 August 2020 © Springer-Verlag GmbH Germany, part of Springer Nature 2020
Abstract Purpose Contemporary, original research should be utilised to inform guidelines in urology relating to the COVID-19 pandemic. This comprehensive review aimed to: identify all up-to-date original publications relating to urology and COVID-19, characterise where publications were from, and outline what topics were investigated. Methods This review utilised a search strategy that assessed five electronic databases, additional grey literature, and global trial registries. All current published, in-press, and pre-print manuscripts were included. Eligible studies were required to be original research articles of any study design, reporting on COVID-19 or urology, in any of study population, intervention, comparison, or outcomes. Included studies were reported in a narrative synthesis format. Data were summarised according to primary reported outcome topic. A world heatmap was generated to represent where included studies originated from. Results Of the 6617 search results, 48 studies met final inclusion criteria, including 8 pre-prints and 7 ongoing studies from online registries. These studies originated from ten countries according to first author affiliation. Most studies originated from China (n = 13), followed by Italy (n = 12) and USA (n = 11). Topics of the study included pathophysiological, administrative, and clinical fields: translational (n = 14), COVID-19-related outcomes (n = 5), urology training (n = 4), telemedicine (n = 7), equipment and safety (n = 2), urology in general (n = 4), uro-oncology (n = 3), urolithiasis (n = 1), and kidney transplantation (n = 8). Conclusion This review has outlined available original research relevant to COVID-19 and urology from the international community. This summary may serve as a guide for future research priorities in this area. Keywords COVID-19 · Urology · Uro-oncology · Training · Telemedicine · Kidney transplantation Abbreviations ACE2 Angiotensin-converting enzyme II ADT Androgen-deprivation therapy AKI Acute kidney injury CI Confidence interval COVID-19 Coronavirus 19 Electronic supplementary material The online version of this article (https://doi.org/10.1007/s00345-020-03434-2) contains supplementary material, which is available to authorized users. * Liang G. Qu [email protected] 1
Olivia Newton John Cancer Research Institute, Austin Health, Melbourne, VIC, Australia
2
Department of Surgery, University of Melbourne, Melbourne, VIC, Australia
3
Department of Urology, Austin Health, Heidelberg, VIC, Australia
EAU European Association of Urology ICU Intensive care unit OR Odds ratio PPE Personal protective equipment pRCC Papillary renal cell carcinoma RNA Ribonucleic acid SARS-CoV-2 Severe acute r
Data Loading...
